Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M C Rosenberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Gastroenterology & Hepatology|June 20, 2002
Success in treating mild chronic hepatitis C: different outcomes -- new guidelines?William M C Rosenberg
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2008
Renal hepatitis C in the absence of detectable serum or hepatic virusAndrew J Fowell, Nicholas Sheron, William M C Rosenberg
Biochemical and Biophysical Research Communications|February 9, 2011
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferationAndrew J Fowell, Jane E Collins, Dale R Duncombe, et al.
Gastroenterology|December 4, 2004
Serum markers detect the presence of liver fibrosis: a cohort studyWilliam M C Rosenberg, Michael Voelker, Robert Thiel, et al.
BMC Pregnancy and Childbirth|December 3, 2013
Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitalsGauri Godbole, Dianne Irish, Marina Basarab, et al.
Hepatology (Baltimore, Md.)|January 16, 2010
Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virusSusanne Knapp, Usama Warshow, Doha Hegazy, et al.
Gastroenterology|July 30, 2002
The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac diseaseJeffrey R Butterworth, Brian T Cooper, William M C Rosenberg, et al.
Journal of Hepatology|June 11, 2018
Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipientsKosh Agarwal, Lluís Castells, Beat Müllhaupt, et al.
Gut|August 17, 2012
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an updateShahid A Khan, Brian R Davidson, Robert D Goldin, et al.
Scientific Reports|July 19, 2017
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosisHarsimran D Singh, Itziar Otano, Krista Rombouts, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Gastroenterology & Hepatology|June 20, 2002
Success in treating mild chronic hepatitis C: different outcomes -- new guidelines?William M C Rosenberg
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2008
Renal hepatitis C in the absence of detectable serum or hepatic virusAndrew J Fowell, Nicholas Sheron, William M C Rosenberg
Biochemical and Biophysical Research Communications|February 9, 2011
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferationAndrew J Fowell, Jane E Collins, Dale R Duncombe, et al.
Gastroenterology|December 4, 2004
Serum markers detect the presence of liver fibrosis: a cohort studyWilliam M C Rosenberg, Michael Voelker, Robert Thiel, et al.
BMC Pregnancy and Childbirth|December 3, 2013
Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitalsGauri Godbole, Dianne Irish, Marina Basarab, et al.
Hepatology (Baltimore, Md.)|January 16, 2010
Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virusSusanne Knapp, Usama Warshow, Doha Hegazy, et al.
Gastroenterology|July 30, 2002
The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac diseaseJeffrey R Butterworth, Brian T Cooper, William M C Rosenberg, et al.
Journal of Hepatology|June 11, 2018
Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipientsKosh Agarwal, Lluís Castells, Beat Müllhaupt, et al.
Gut|August 17, 2012
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an updateShahid A Khan, Brian R Davidson, Robert D Goldin, et al.
Scientific Reports|July 19, 2017
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosisHarsimran D Singh, Itziar Otano, Krista Rombouts, et al.
Pageof 2